Medicine that Causes Memory Loss: Risk of Neurocognitive Disorders

References (68)

1. 1 The World Health Report 2002 - Reducing Risks, Promoting Healthy Life [DOI]
2. 2 Patient Medication Adherence: Measures in Daily Practice [DOI]
3. 3 The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons [DOI]
4. 4 Global Epidemiology of Dementia: Alzheimer’s and Vascular Types [DOI]
5. 5 The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity [DOI]
6. 6 Benzodiazepine pharmacology and central nervous system-mediated effects.
7. 7 Basic and Clinical Pharmacology [DOI]
8. 8 Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer [DOI]
9. 9 Lippincott's Illustrated Reviews: Pharmacology
10. 10 The cognitive impact of antiepileptic drugs [DOI]
11. 11 Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature [DOI]
12. 12 Long-Term Benzodiazepine Use and Cognitive Decline in the Elderly: The Epidemiology of Vascular Aging Study [DOI]
13. 13 Inequality: an underacknowledged source of mental illness and distress [DOI]
14. 14 Cambridge Handbook of Psychology, Health and Medicine [DOI]
15. 15 Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo [DOI]
16. 16 Associations Between Drug Burden Index and Falls in Older People in Residential Aged Care [DOI]
17. 17 Physical and Cognitive Performance and Burden of Anticholinergics, Sedatives, and ACE Inhibitors in Older Women [DOI]
18. 18 Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? [DOI]
19. 19 Serotonin Receptors in Hippocampus [DOI]
20. 20 Drug Burden Index and physical function in older Australian men [DOI]
21. 21 H1 Antihistamines: Current Status and Future Directions [DOI]
22. 22 Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development [DOI]
23. 23 Enhancement of GABAergic Activity: Neuropharmacological Effects of Benzodiazepines and Therapeutic Use in Anesthesiology [DOI]
24. 24 Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin [DOI]
25. 25 Classification of Neurocognitive Disorders in DSM-5: A Work in Progress [DOI]
26. 26 Rapid urbanization - Its impact on mental health: A South Asian perspective [DOI]
27. 27 Benzodiazepines Modulate GABAAReceptors by Regulating the Preactivation Step after GABA Binding [DOI]
28. 28 Anticholinergic Drug Burden in Older People's Brain - How well is it Measured? [DOI]
29. 29 Feeling and Time: The Phenomenology of Mood Disorders, Depressive Realism, and Existential Psychotherapy [DOI]
30. 30 Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity [DOI]
31. 31 The Effect of HMG-CoA Reductase Inhibitors on Cognition in Patients With Alzheimer's Dementia: A Prospective Withdrawal and Rechallenge Pilot Study [DOI]
32. 32 Technologies for Assessment of Motor Disorders in Parkinson’s Disease: A Review [DOI]
33. 33 Acetylcholine and Delirium [DOI]
34. 34 Assessment and management of pain in infants [DOI]
35. 35 Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes [DOI]
36. 36 Typical absence seizures and their treatment [DOI]
37. 37 Drug Management of Visceral Pain: Concepts from Basic Research [DOI]
38. 38 Carvedilol in hypertension treatment [DOI]
39. 39 Anticholinergic Drug Use and Mortality Among Residents of Long-Term Care Facilities: A Prospective Cohort Study [DOI]
40. 40 An Integrative Review of Sleep for Nutrition Professionals [DOI]
41. 41 Acetylcholine: Future research and perspectives [DOI]
42. 42 Alzheimer Disease and Other Dementias [DOI]
43. 43 Short‐Term Memory Loss Associated with Rosuvastatin [DOI]
44. 44 Opioids for managing chronic non-malignant pain: safe and effective prescribing.
45. 45 Determinants of antipsychotic medication use among older people living in aged care homes in Australia [DOI]
46. 46 Methods for Assessing Drug‐Related Anticholinergic Activity [DOI]
47. 47 The Destructive Capacity of Drug Abuse: An Overview Exploring the Harmful Potential of Drug Abuse Both to the Individual and to Society [DOI]
48. 48 Cognitive function of idiopathic childhood epilepsy [DOI]
49. 49 Addressing the Issue of Chronic, Inappropriate Benzodiazepine Use: How Can Pharmacists Play a Role? [DOI]
50. 50 Antidepressant Interactions with the NMDA NR1-1b Subunit [DOI]
51. 51 Tricyclic antidepressant pharmacology and therapeutic drug interactions updated [DOI]
52. 52 GOODMAN AND GILMAN'S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS [DOI]
53. 53 Influence of Low High-Density Lipoprotein Cholesterol and Elevated Triglyceride on Coronary Heart Disease Events and Response to Simvastatin Therapy in 4S [DOI]
54. 54 Epidemiology of Parkinson’s Disease [DOI]
55. 55 Early Dementia Screening [DOI]
56. 56 Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms [DOI]
57. 57 Obstructive sleep apnoea syndrome: underestimated and undertreated [DOI]
58. 58 Treatment of Hypertension in Adults With Diabetes [DOI]
59. 59 Neurotransmitters and memory: Role of cholinergic, serotonergic, and noradrenergic systems. [DOI]
60. 60 Family Triad Perceptions of Mild Cognitive Impairment [DOI]
61. 61 Treating Anxiety with either Beta Blockers or Antiemetic Antimuscarinic Drugs: A Review [DOI]
62. 62 Epidemiology of Parkinson’s disease [DOI]
63. 63 Mutations of the Calcium Channel Gene cacophony Suppress Seizures in Drosophila [DOI]
64. 64 Cambridge handbook of psychology health and medicine [DOI]
65. 65 Innovation and Validation of Neuropsychopharmacological Testing Methods for the Assessment of Memory, Attention and Cognition in Human Participants [DOI]
66. 66 Alzheimer’S Disease: A Brief Quintessence Medical Management Study [DOI]
67. 67 What is urinary incontinence?
68. 68 International Journal of Clinical Practice [DOI]

Cited by 24

Showing 11 of 24 known citations — external sources report more than can currently be individually listed.

Related research

• Regions and Sub-regions Dysfunctions in Alzheimer’s during Rest — shares topic coverage
• An Overview on the Aetiology and Treatment of Alzheimer's Disease — shares topic coverage
• Dementia Diagnosis and Alternate Treatment: A Recent Update on Treatment Options — shares topic coverage
• The Brain Cholinergic System in Neurodegenerative Diseases — shares topic coverage
• Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants — shares topic coverage